Clinical Trials Logo
  1. Home
  2. Masked Hypertension
  3. NCT02156024

The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension

Masked Hypertension Clinical Trial

Clinical Trial Summary

The purpose of this study is

1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years.

2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02156024
Study type Interventional
Source Shanghai Institute of Hypertension
Contact Yan Li, doctor
Phone 021-64370045
Email liyanshcn@yahoo.com
Status Recruiting
Phase Phase 4
Start date March 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02804074 - MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement N/A
Active, not recruiting NCT02503943 - Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes Phase 4
Completed NCT02142881 - Treatment of Masked Hypertension Phase 3
Active, not recruiting NCT04200716 - Arterial Function After Two Different Physical Exercise Intensities in Prehypertension N/A
Not yet recruiting NCT05409898 - Screening for Masked Hypertension With Smart Wearable Devices (SMART)
Withdrawn NCT04121299 - Mechanism of Masked Hypertension - Intervention Phase 3
Active, not recruiting NCT02893358 - Antihypertensive Treatment in Masked Hypertension for Target Organ Protection Phase 4
Recruiting NCT02663336 - Prevalence of Masked Hypertension in Nephrological Patients
Completed NCT04251975 - Masked Hypertensive Patients With Obstructive Sleep Apnea N/A